Aquestive Therapeutics, Inc. (AQST) Stock Analysis

Free AI-powered analysis and research for Aquestive Therapeutics, Inc. stock

Sector: Healthcare

Analyze Aquestive Therapeutics, Inc. (AQST) Stock

Aquestive Therapeutics, Inc. (AQST) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into AQST stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Aquestive Therapeutics, Inc. stock.

Analyze AQST Now →

📰 Latest Update

Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

Thu, September 17, 2026 at 11:00 AM UTC 2 min read

Aquestive Therapeutics has announced the resubmission of its New Drug Application (NDA) to the FDA for Anaphylm™ (dibutepinephrine) sublingual film, a treatment aimed at addressing severe allergic reactions. This resubmission is significant for investors as it could pave the way for potential FDA approval, enhancing the company's product portfolio and revenue prospects. Successful approval may also bolster investor confidence and positively impact AQST's stock performance in the near future.

Read full article →